BioCentury
ARTICLE | Company News

FDA approves Boehringer's Jardiance

August 2, 2014 1:12 AM UTC

FDA approved Jardiance empagliflozin from Boehringer Ingelheim GmbH (Ingelheim, Germany) to treat Type II diabetes. The company said it plans to launch the sodium-glucose cotransporter 2 (SGLT2) inhib...